23 May 2013
Keywords: positive, results, decode, dg031, iceland-based, genetics, released
Article | 25 October 2004
Iceland-based deCODE genetics has released promising data from a Phase IIa trial evaluating the effect of its DG031 on certain ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 October 2004
1 November 2004
© 2013 thepharmaletter.com